Neuralstem

YTD

ALL

Why Robinhood?

You can watch Neuralstem and buy or sell other stocks, ETFs, and their options commission-free!

About CUR

Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform.

CEO

Thomas Hallam, PhD

CEOThomas Hallam, PhD

Employees

Employees8

Headquarters

Germantown, Maryland

HeadquartersGermantown, Maryland

Founded

1996

Founded1996

Employees

Employees8

CUR Key Statistics

Market cap

7.30M

Market cap7.30M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Stock Snapshot

Neuralstem(CUR) stock is priced at $1.52, giving the company a market capitalization of 7.3M.

On 2026-03-11, Neuralstem(CUR) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.